Health News
Depression and a Declining Mind
Healthcare providers have been searching for ways to reduce the risk for developing dementia. Treating depression may, in some way, help the mind stay sharp.
A Bone to Pick with IBS
With certain stomach and intestinal tract conditions, weak bones can result. The same holds true for patients with abnormal bowel movements.
Race and Risk of MS
For many years, researchers have believed that multiple sclerosis (MS) was less common in African Americans than in whites. A new study now questions that long-held belief.
Valproate Anti-seizure Products Contraindicated for Migraine Prevention in Pregnant Women
The US Food and Drug Administration (FDA) is advising healthcare professionals and women that the anti-seizure medication valproate sodium and related products, valproic acid and divalproex sodium, are contraindicated and should not be taken by pregnant women for the prevention of migraine headaches.
Anesthesia's Impact After Joint Surgery
If you're about to get a hip or knee replacement, you're going to need anesthesia to numb the pain during surgery. There are different types of anesthesia to choose from. So which one leads to the best outcomes?
No Time to Hesitate Before Hip Surgery
Older adults who take a bad fall or blow to the hip might need to act quickly. If the hip's fractured, there's no time to delay.
Embrace the Knee Brace
It's been established that braces for the knees can provide relief from pain and protection from injury. But until now, not much was known on whether knee braces can pinpoint pain in the kneecap.
A Pregnancy Dilemma for a Medication?
Some medications are linked to disorders such as autism or to birth defects when taken during pregnancy. However, that risk must also be balanced against the medication's benefits.
Ladies Not Taking Brittle Bone Rx
Many women haven’t been taking their prescriptions to treat bone loss from their osteoporosis. Money may not have anything to do with the lack of following doctor’s orders.
New Drug Application for Amitiza Approved
Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals USA, Inc. announced today that the FDA has approved Sucampo’s supplemental new drug application (sNDA) for AMITIZA ® (lubiprostone) (24 mcg twice daily) as the first and only oral medication for the treatment of opioid-induced constipation (OIC) in adult patients with chronic, non-cancer pain.